{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-009122","form_type":"8-K","ticker":"RNAZ","cik":"0001829635","company_name":"Transcode Therapeutics, Inc.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.132533+00:00","generated_at":"2026-05-27T03:36:54.175688+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"TransCode Therapeutics adjourns special meeting; only 29.94% of shares voted, below quorum","bullets":["Special meeting held Feb 4, 2025 lacked quorum (needs one-third of outstanding shares); only 29.94% voted.","Meeting reconvenes Feb 25, 2025 at 9:30 a.m. ET virtually; record date remains Dec 17, 2024.","Proposals include approval of warrant share issuance (Series C and D) and an adjournment proposal.","Company continues soliciting votes; stockholders can vote by mail, internet, phone, or at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-009122","json":"https://secwatch.observer/filing/0001104659-25-009122.json","markdown":"https://secwatch.observer/filing/0001104659-25-009122.md","text":"https://secwatch.observer/filing/0001104659-25-009122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925009122/0001104659-25-009122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925009122/tm255410d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:36:54.175688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}